NG CAREY purchased 100.0% of their position (10K shares) of IMMIX BIOPHARMA, INC. on the open market
Open‑market purchase worth $18.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/19/2024ACC: 0001493152-24-033205
+10K
Net shares
Net buyer
$18.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$1.86
Trade value
$18.60K
% of position
100.0%
8/16/2024
10K→20K
Total
Net shares
+10K
Net value
$18.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2024 | P · Purchase | +10K | $1.86 | $18.60K | 100.0% | 10K | 20K |
| Total | +10K | $18.60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.03M
Total
1.03M indirect1.03M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.03M | Indirect |
| Total | 1.03M | 1.03M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported